Sort
78,016 grants matching “breast cancer”
Cooperative Human Tissue Network Support through Duke's BioRepository & Precision Pathology Center
$719,670Shannon Jones McCall · Duke University · UM1 · FY2024 · CA
A high resolution and high DQE detector optimized for mammography using single-shot bi-directional tri-contrast imaging
$719,633Wenbing Yun · Sigray, Inc. · R44 · FY2017 · EB
DEVELOPING RATIONALIZED THERAPEUTIC STRATEGY TO TARGET ADVANCED STAGE TRIPLE-NEGATIVE BREAST CANCER
$719,550University Of Illinois · · FY2022 · Defense Health Agency
FANCONI ANEMIA:GENOTYPE-PHENOTYPE CORRELATIONS
$719,494Settara Chandrasekharappa · National Human Genome Research Institute · ZIA · FY2015 · HG
Intervention Trials in Persons at Increased Genetic Risk of Cancer
$719,464Sharon A. Savage · Division Of Cancer Epidemiology And Genetics · ZIA · FY2018 · CA
LEGACY: A Cohort of Youth in Families from the Breast Cancer Family Registry
$719,450Esther M John · Cancer Prevention Instit Of California · R01 · FY2012 · CA
Clinical Pharmacogenetics
$719,430William Douglas Figg · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Synthetic introns for selective targeting of RNA splicing factor-mutant leukemia
$719,414Robert K Bradley · Fred Hutchinson Cancer Center · R01 · FY2025 · CA
Epigenetic damage in women living in LA food-desert zip codes
$719,296Victoria L. Seewaldt · Beckman Research Institute/City Of Hope · R01 · FY2017 · CA
Functional Analysis of Variants Identified in Human Breast Cancer Susceptibility
$719,226Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Functional Analysis of Breast Cancer Susceptibility Genes in Mice
$719,226Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Preventing Anthracycline Cardiovascular Toxicity with Statins
$719,147William Gregory Hundley · Wake Forest University Health Sciences · R01 · FY2013 · HL
Behavioral Influences on Ovarian Cancer Progression: Role of Chemoresistance
$719,070Susan K Lutgendorf · University Of Iowa · R01 · FY2019 · CA
Development of an inhibitor of VEGF expression
$719,008Ptc Therapeutics, Inc. · R44 · FY2005 · CA
Developing Informatics Technologies to Model Cancer Gene Regulation
$718,986Clifford Meyer · Dana-Farber Cancer Inst · U24 · FY2023 · CA
A Unique Class of Reductively Activated Oncology Drugs
$718,986Dale L Boger · Scripps Research Institute, The · R01 · FY2021 · CA
A Unique Class of Reductively Activated Oncology Drugs
$718,986Dale L Boger · Scripps Research Institute, The · R01 · FY2017 · CA
A Unique Class of Reductively Activated Oncology Drugs
$718,986Dale L Boger · Scripps Research Institute, The · R01 · FY2020 · CA
A Unique Class of Reductively Activated Oncology Drugs
$718,986Dale L Boger · Scripps Research Institute, The · R01 · FY2018 · CA
Promoting Equity of Cancer Screening and Follow-up for Lung Cancer
$718,974Chyke Abadama Doubeni · Ohio State University · R01 · FY2023 · CA
Protein Sequencing by Tandem Mass Spectrometry
$718,968Donald F Hunt · University Of Virginia · R01 · FY2017 · GM
Protein Sequencing by Tandem Mass Spectrometry
$718,968Donald F Hunt · University Of Virginia · R01 · FY2018 · GM
Protein Sequencing by Tandem Mass Spectrometry
$718,968Donald F Hunt · University Of Virginia · R01 · FY2015 · GM
Protein Sequencing by Tandem Mass Spectrometry
$718,968Donald F Hunt · University Of Virginia · R01 · FY2016 · GM
Environmental Regulation of Cancer Stem Cell Plasticity in Metastasis
$718,923Gary D Luker · University Of Michigan At Ann Arbor · U01 · FY2018 · CA